Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association

NEXT STORY
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
PREV STORY
Aptinyx Reports Positive Top-line Data from Phase 2 Study of NYX-2925 in Patients with Fibromyalgia, Demonstrating Significant Effects on Both Biomarkers and Patient-Reported Pain
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cortice Biosciences Announces an Upcoming Presentation at the 2017 American Society of Clinical Oncology Annual Meeting

NEW YORK, May 18, 2017 (GLOBE NEWSWIRE) -- Cortice Biosciences announced today that final ...

author_avatar
NASDAQ Market News

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

author_avatar
NASDAQ Market News

Innate Pharma to Present New Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ASCO20 Virtual Scientific Program

author_avatar
NASDAQ Market News